U.S. Consumer Durables Stock News

Key Insights Intapp's Annual General Meeting to take place on 18th of November Salary of US$501.0k is part of CEO John...

Rubrik (RBRK) announced a new strategic collaboration agreement with Amazon Web Services. The partnership aims to advance cybersecurity and AI-powered data protection for organizations using the cloud. This move highlights Rubrik’s focus on strengthening cyber resilience and recovery capabilities. See our latest analysis for Rubrik. Rubrik’s strategic tie-up with AWS has sparked investor enthusiasm, as shown by a 4.16% jump in the share price on the day of the announcement. While the last...

Ever looked at First BanCorp and wondered if the price on the screen genuinely matches what the business is worth? You are not alone; deciphering value in banks like this can be both fascinating and rewarding. Over the past year, the stock has dipped slightly by 3%. Zooming out to five years, it has risen by 187.3%, suggesting significant growth potential and shifting market sentiment. First BanCorp has found itself in investor headlines lately as regional banks respond to industry trends...

When close to half the companies in the Chemicals industry in the United States have price-to-sales ratios (or "P/S...

Lucid Group (LCID) sparked discussion this week after its third-quarter results fell short of investor expectations, which triggered several big moves. Fresh executive appointments, new technology collaborations, and a headline deal with Uber were all announced alongside the earnings. See our latest analysis for Lucid Group. Amid all the announcements, Lucid’s share price has shown little near-term relief. Its 1-year total shareholder return is down 26.6%, and the year-to-date share price...

Fabrinet ( NYSE:FN ) shareholders have had their patience rewarded with a 29% share price jump in the last month...

Zymeworks (ZYME) just released its third quarter earnings, showing a much smaller net loss than last year. The improvement highlights real financial progress and could lead investors to take a closer look at the company’s operations. See our latest analysis for Zymeworks. After a standout earnings report and a recent board reshuffle, Zymeworks is drawing fresh attention. The share price has climbed 29% over the past three months, showing momentum that contrasts with more modest gains in its...

Key Insights Hitek Global's significant private companies ownership suggests that the key decisions are influenced by...

Ally Financial Inc. recently reported its Q3 2025 results, emphasizing improvements in its capital ratios, robust growth in dealer financial services, and a renewed focus on digital banking and higher-yielding core businesses while exiting less profitable operations. Additionally, the company appointed Allan Merrill, CEO of Beazer Homes, and Gunther Bright, a former American Express executive, to its board, signaling further emphasis on leadership expertise and business...

With a price-to-earnings (or "P/E") ratio of 42x Woodward, Inc. ( NASDAQ:WWD ) may be sending very bearish signals at...

Xenia Hotels & Resorts recently reported a third-quarter net loss of US$13.74 million on revenue of US$236.42 million, and lowered its full-year 2025 earnings guidance, attributing the change to macroeconomic uncertainty. Alongside the earnings update, Xenia completed a significant share buyback tranche, repurchasing 974,645 shares in the last quarter and bringing total buybacks since December 2015 to 23.93% of its shares outstanding for US$340.93 million. We'll explore how Xenia's reduced...

ORIC Pharmaceuticals (ORIC) recently sparked fresh discussion after publishing research showcasing its cancer drug enozertinib’s targeted activity against EGFR exon 20 mutations in non-small cell lung cancer. Investors are watching for more data at future conferences. See our latest analysis for ORIC Pharmaceuticals. ORIC Pharmaceuticals' momentum has picked up speed, with enthusiasm around its enozertinib data fueling a remarkable 50.9% share price return so far this year and lifting the...

Parsons (PSN) is making headlines after securing a major contract to modernize the U.S. Coast Guard's Biometrics at Sea System, as well as new infrastructure and security projects in the Middle East. These wins reinforce the company's presence in essential government and security sectors. See our latest analysis for Parsons. Even as Parsons continues to win high-profile contracts this year, including major U.S. Coast Guard and Middle East projects, the stock's momentum has been mixed. The...

Key Insights The projected fair value for Gyre Therapeutics is US$8.62 based on 2 Stage Free Cash Flow to Equity With...

The St. Joe Company ( NYSE:JOE ) shares have had a really impressive month, gaining 25% after a shaky period...

When close to half the companies operating in the Healthcare industry in the United States have price-to-sales ratios...

Watsco, Inc. ( NYSE:WSO ) just released its latest quarterly report and things are not looking great. Results look to...

Key Insights Significant control over Context Therapeutics by private equity firms implies that the general public has...

Perma-Fix Environmental Services, Inc. ( NASDAQ:PESI ) shares have had a really impressive month, gaining 42% after a...

908 Devices Inc. ( NASDAQ:MASS ) insiders who acquired shares over the previous 12 months, can probably afford to...

Active investing isn't easy, but for those that do it, the aim is to find the best companies to buy, and to profit...

Quite a few insiders have dramatically grown their holdings in Clear Channel Outdoor Holdings, Inc. ( NYSE:CCO ) over...

Imperial Petroleum Inc. ( NASDAQ:IMPP ) shares have continued their recent momentum with a 35% gain in the last month...

We can readily understand why investors are attracted to unprofitable companies. For example, Forte Biosciences...